AHA 2020 | Physician's Weekly
Advertisement

AHA 2020

AHA 2020 Quiz Answers!

1) According to the FOURIER trial, patients treated with PCSK9 inhibitors had a reduced risk for venous thromboembolism (VTE), especially if they had elevated what? a) LDL b) Lipoprotein(a) c) Both d) None of the above The...

AHA Scientific Sessions 2020 – eBook

AHA 2020: A Focus on Hyperlipidemia Featuring Inclisiran effective across age and genders for hyperlipidemia No Age Cap for Lipid-Lowering Therapy Polypill Plus Aspirin Prevents Cardiovascular Events PCSK9 inhibition as primary...

AHA 2020: No Age Cap for Lipid-Lowering Therapy

Two complimentary papers presented at the American Heart Association Scientific Sessions 2020 Virtual meeting, and published back to back in the Lancet [1,2], showed strong evidence that individuals aged over 70 years benefit at...

Loading